immatics biotechnologies GmbH Working Capital to Net Assets Ratio
immatics biotechnologies GmbH working capital to net assets ratio. immatics biotechnologies GmbH (IMTXW) has a Working Capital to Net Assets ratio of 96.5% as of March 2025. Working capital of $517.79 Million (current assets of $573.56 Million minus current liabilities of $55.77 Million) is measured against net assets of $536.61 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check immatics biotechnologies GmbH (IMTXW) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of immatics biotechnologies GmbH (2018–2024)
Working capital to net assets ratio of immatics biotechnologies GmbH from 2018 to 2024. This chart shows how immatics biotechnologies GmbH's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2018 to 2024. As of March 2025, the ratio stands at 96.5%, reflecting working capital of $517.79 Million against net assets of $536.61 Million USD. See immatics biotechnologies GmbH (IMTXW) defensive interval to measure how many days the company can operate on defensive assets alone.
immatics biotechnologies GmbH Working Capital to Net Assets Ratio by Year (2018–2024)
immatics biotechnologies GmbH working capital to net assets ratio by year from 2018 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for immatics biotechnologies GmbH from 2018 to 2024, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of immatics biotechnologies GmbH.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 97.7% | $561.57 Million | $574.84 Million | $629.55 Million | $67.99 Million | ▼ -32.4 pp |
| 2023 | 130.1% | $292.82 Million | $225.08 Million | $449.37 Million | $156.55 Million | ▲ +3.1 pp |
| 2022 | 127.0% | $270.70 Million | $213.16 Million | $377.15 Million | $106.45 Million | ▼ -110.1 pp |
| 2021 | 237.1% | $57.06 Million | $24.06 Million | $152.21 Million | $95.15 Million | ▲ +66.0 pp |
| 2020 | 171.1% | $178.38 Million | $104.26 Million | $238.99 Million | $60.61 Million | ▲ +305.1 pp |
| 2019 | -134.0% | $54.70 Million | $-40.84 Million | $124.00 Million | $69.30 Million | ▲ +176.3 pp |
| 2018 | -310.2% | $28.45 Million | $-9.17 Million | $55.29 Million | $26.84 Million | — |